Patent Assignment
Reel/Frame 058085/0882
Assignment of Assignor's Interest
Recorded: 2021-11-11
Pages: 3
Assignee
MYELOID THERAPEUTICS, INC.
300 TECHNOLOGY SQUARE, SUITE 203, CAMBRIDGE, MASSACHUSETTS, 02132
Covered Property
(1)
Engineered Chimeric Fusion Protein Compositions and Methods of Use Thereof
Application:
17/514,828 →
Publication:
US 2022/0378824
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.